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Abstract 
Candidemia is an associated with a high mortality rate, and initial adequate antifungal therapy 
results in a significant decrease in the crude mortality. We herein report a rapid method that 
can identify eight Candida species in candidemia using imperfect match quenching probes 
(IM Q-probes) within three and a half hours of whole blood sample collection. Furthermore, 
employing the D value, which reflects the difference between the Tm signature from a 
clinical isolate and that registered in the database, it is possible to quickly identify samples 
suitable for IM Q-probe identification. We first evaluated the method using 34 Candida 
colonies collected from different patients, and 100% (34/34) of the identification results 
matched the preidentified Candida species. We then performed blind tests using eight whole 
blood samples artificially mixed with eight different Candida species respectively, and all 
identification results correctly matched the preidentified Candida species. Finally, using 16 
whole blood samples collected from candidemia patients, we compared the IM Q-probe 
method with the culture/sequencing method. Of a total of 16 patient samples, 100% (16/16) 
matched the culture and sequencing results. The IM Q-probe method is expected to contribute 
not only to the life expectancy of candidemia patients but also to antifungal stewardship. 
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Candida species are the most common organisms involved in invasive fungal infections and 
major causes of not only local mucous membrane infections but also widespread 
dissemination with multisystem organ failure1. Recently, due to advances in medicine, such 
as major surgery (particularly abdominal surgery), dialysis and immunosuppressants, the 
rates of invasive candidiasis have been increasing. Indeed, in the United States, Candida 
species are the fourth-most common cause of nosocomial bloodstream infection2, 3. 
Candidemia has an associated mortality that is as high as 25%, and initial adequate antifungal 
therapy results in a significant decrease in the crude mortality4-6. However, blood cultures 
usually take two to five days to finalize, leading to a significant delay in the implementation 
of culture-driven therapy1,7,8. In addition, although most episodes of candidemia are still 
caused by Candida albicans, opportunistic infections due to non-C. albicans species have 
been reported with increasing frequency9. 
Pfaller et al. reported that the trends in descending order of frequency of Candida 
species causing candidemia were C. albicans (42.1%), C. glabrata (26.7%), C. parapsilosis 
(15.9%), C. tropicalis (8.7%), C. krusei (3.4%), C. lusitaniae (1.1%), C. dubliniensis (0.9%) 
and C. guilliermondii (0.4%)10. Because definitive therapy by selecting an appropriate anti-
Candida agent should be based on the species of Candida, the rapid and accurate 
identification of Candida species is critical for the prompt initiation of appropriate therapy1. 
Niimi et al. reported the novel “melting temperature mapping method” for rapidly 
identifying the dominant bacteria in a clinical sample from a sterile site11, which is our 
previous teamwork. This study suggested that more than 100 bacterial species can be 
identified by employing the melting temperatures (Tm) of 7 primer sets, and these findings 
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can be obtained within three hours of whole blood collection. This method is useful for 
identifying bacteria. However, regarding the identification of Candida species, it is more 
difficult to design universal primers for fungi than for bacteria since Candida species are 
eukaryotes, like human cells. In addition, to identify many kinds of Candida species at the 
species level, specific primers must be generally prepared for each Candida species. As a 
result, the system becomes more complicated and more costly. 
To address these problems, we herein report the development of a rapid, easy and cost-
effective method for identifying Candida species in candidemia using a real-time polymerase 
chain reaction (PCR)-based system. 
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Results 
Workflow of the rapid identification method for eight Candida species 
The workflow of the rapid identification method for Candida species developed in our 
laboratory is shown in Fig. 1A. Employing Candida universal PCR (using one Candida 
universal primer) and a melting temperature (Tm) value analysis of three probes, eight 
Candida species were able to be identified within three and a half hours of whole blood 
collection.  
The eight Candida species causing candidemia were selected based on the trends in 
descending order of frequency, as described above10. This method consists of four major 
steps. First, fungal DNA is directly extracted from a clinical sample (e.g. 2 mL of whole 
blood sample) as a template for PCR. Step two involves PCR using a Candida universal 
primer and three imperfect match quenching probes (IM Q-probes). The Candida universal 
primer can detect all species of Candida. The three PCR reaction mixtures (three PCR tubes) 
contain the same Candida universal primer set and each IM Q-probe. We designed three IM 
Q-probes (IM Q-probe 1, IM Q-probe 2, IM Q-probe 3) that were able to bind to the positions 
with some probe-target base sequence mismatches in the same Candida universal PCR 
amplicon (Fig. 1B, Table 1). Allowing for some probe-target base sequence mismatches, 
there is substantial flexibility in these IM Q-probe designs. To obtain stable Tm values (and 
therefore stable identification results), we carefully selected each probe position whose target 
base sequence was the same among the different strains of the same Candida species reported 
in the DNA Data Bank of Japan (Table S1). PCR was then performed, and one PCR amplicon 
was obtained. In step three, the three Tm values were acquired by analyzing each IM Q-probe. 
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Each of the Tm values varied depending on Candida species. The Tm value analysis showed 
various melting peaks (i.e. Tm values) among the eight Candida species with each IM Q-
probe (Fig. S1). Consequently, the combination of the three Tm values was Candida species-
specific (Fig. 2). In C. glabrata and C. lusitaniae, using the IM Q-probe 1, Tm values could 
not be obtained because of the large number of probe–target mismatches. Step four involved 
the identification of Candida species by comparing each of three Tm values with the database. 
We constructed a preliminary database of the eight Candida species showing the mean values 
of triplicate Tm measurements (Table S2). Candida isolates were able to be rapidly identified 
by comparing the Tm values to the values in the database. 
In order to identify a Candida isolate, we calculated the difference (D) value using the 
formula shown in Fig. 3. The D value reflects the difference between the Tm signature from 
a clinical isolate and that registered in the database. Candida species were identified by 
comparing the three distances from the average of a Candida isolate to those in the database. 
Tm values above the average received a “+” designation, while those below the average 
received a “-” designation. The known Candida species in the database with the smallest D 
value was then identified as a correct match. 
 
The assessment of the accuracy of the IM Q-probe method 
In order to assess the accuracy of the IM Q-probe method, we first validated the measurement 
error. Using the Rotor-Gene Q instrument, whose tube-to-tube variation is within ± 0.1 °C, 
we tried to validate the measurement errors among 10 samples using the same C. albicans 
DNA template in the same trial (Table S3). The results showed that the maximum 
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measurement error of the IM Q-probes was ± 0.25 °C. On receiving this result, we then 
established preliminary interpretative criteria to assess the suitability of the IM Q-probe 
identification. The interpretative criteria for identification based on the D value are shown in 
Table 2. Considering the maximum measurement error of the IM Q-probes, identification 
results with a D value of ≤ 0.41 are considered the Candida isolate. To determine the D 
threshold (= 0.41), we calculated it employing three Tm degrees (+0.25, -0.25, +0.25) and 
the formula (Fig. 3). If the IM Q-probe method shows identification results with D values of 
> 0.41, the identification result with the lowest D value is highly likely to be the Candida 
isolate due to the high specificity of the IM Q-probe identification (Table S4). C. lusitaniae 
and C. glabrata are narrowed down as pathogen, but cannot be distinguished using the D 
value only. In this case, it is easy to distinguish them by checking the difference in their Tm 
values already obtained, which are apparently different (Table S2). In addition, using the 
current protocols, the limit of identification of the IM Q-probe method is 1.2 CFU of C. 
albicans per PCR tube (Table S5).  
     We subsequently evaluated the accuracy of the IM Q-probe method using 34 Candida 
colonies (8 Candida species) obtained from various type of samples (blood, sputum and 
urine) collected from different patients (Table 3). As a result, 100% (34/34) of the IM Q-
probe results, whose D values were all ≤ 0.41, correctly matched the pre-identified Candida 
species by the sequencing method. 
In order to assess the IM Q-probe method, we then performed blind tests using the 
whole blood samples artificially mixed with Candida species (200 CFU of Candida species 
per 2 mL of healthy whole blood). After concealing the name of Candida species, we tried 
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to identify the Candida species in the whole blood. In all eight trials with eight different 
Candida species respectively, the IM Q-probe results, whose D values were all ≤ 0.41, 
correctly matched the pre-identified Candida species by the sequencing method (Table 4). 
     Finally, using 16 whole blood samples (2 mL) collected from candidemia patients, we 
assessed the accuracy of the IM Q-probe method compared that of the culture/sequencing 
method. The individual IM Q-probe results compared with the culture and sequencing results 
are shown in Table 5. Of the total of 16 patient samples, 100% (16/16) matched the culture 
and sequencing results with D values of ≤ 0.41. The breakdown of the identification results 
was, 11 cases of C. albicans, 4 cases of C. parapsilosis, and 1 case of C. tropicalis. 
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Discussion 
In relation to fungal infection, rapid identification methods of Candida species using a high-
resolution melting-curve (HRM) analysis have been previously reported12-14. None of those 
reports used whole blood samples collected from candidemia patients to assess the accuracy 
of their rapid identification methods. HRM analyses primarily rely on differences in the 
melting curve shapes. The IM Q-probe method does not use melting curve shapes, instead 
relying only on Tm values. For this reason, although melting curve shapes are affected by 
various DNA concentrations15, Tm values are not. In fact, fungal concentrations in 
candidemia vary among individual patients. 
Mylonakis et al. reported the utility of a T2 magnetic resonance (T2MR) assay for the 
rapid diagnosis of candidemia in whole blood16,17. Using a T2MR assay, Candida species 
can be detected directly from a clinical sample with high sensitivity. However, the T2MR 
assay detects only five kinds of Candida species (C. albicans, C. glabrata, C. parapsilosis, 
C. tropicalis, and C. krusei). Furthermore, to identify the Candida species, gene sequencing 
analyses are additionally needed. In general, gene sequencing analyses tend to be costly and 
therefore have limited applications for identifying pathogens in clinical practice. 
Employing only one Candida universal primer and three probes, the IM Q-probe 
method enabled the rapid detection and identification of the eight Candida species within 
three and a half hours of whole blood collection. These findings suggest that this method is 
rapid, easy to perform and cost-effective for identifying pathogenic Candida species in cases 
of candidemia. If different-colored fluorescent IM Q-probes are employed, multiplexing in a 
single tube might be possible, which equates to even easier performance. 
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In order to identify various Candida species, we designed quenching probes with some 
probe-target mismatches. Based on the nearest neighbor thermodynamic theory18,19, the 
variations in melting temperature of the IM Q-probes depend on the number and position of 
probe-target mismatches on IM Q-probe hybridization. For this reason, the Tm values of the 
IM Q-probes provided adequate diversity for the IM Q-probe method to identify the eight 
Candida species at the species level. Chakravorty et al. reported the rapid identification of 
bacterial isolates using a sloppy molecular beacon (SMB) melting temperature signature 
technique20. SMB probes possess relatively long probe sequences, enabling them to form 
hybrids with PCR amplicons despite the presence of mismatched base pairs. However, we 
designed the imperfect-match "Q probes" so as not to form secondary structures, since Q 
probes tend to self-quench by forming secondary structures. To obtain stable identification 
results, we selected IM Q-probe positions whose target base sequence was the same among 
different strains of the same Candida species. If the IM Q-probe method identifies a mutant 
strain (D value > 0.41) with a mutation in the IM Q-probe target regions, we will register it 
in the database. Consequently, the IM Q-probe method would be able to identify mutant 
strain as well. In addition, to obtain stable identification results, the pH and salt concentration 
of the PCR buffer should be consistent. Therefore, preparing a reagent kit is advised. 
We first set the interpretative criteria to assess the suitability of the IM Q-probe 
identification. Considering the maximum measurement error of the IM Q-probes (± 0.25 °C) 
using Rotor-Gene Q instrument whose tube-to-tube variation was within ± 0.1 °C, the 
identification results with a D value ≤ 0.41 were considered the Candida isolate. This 
interpretative criterion with the D value can be revised according to the maximum 
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measurement error, and the tube-to-tube variation caused by each real-time PCR instrument 
is the main component of the maximum measurement error. The tube-to-tube variations in 
almost all commercially available real-time PCR instruments are within ± 0.3 to ± 0.5 °C. If 
the maximum measurement error is within ± 0.8 °C, then the range in the theoretical D value 
should be within 1.31. Considering this range of D value and the high specificity of the IM 
Q-probe method (Table S4 shows the D value between the most similar Candida species in 
the database is 2.98), almost all commercially available real-time PCR instruments can 
feasibly be used for the IM Q-probe method to rapidly identify any of eight Candida species 
in a clinical sample. 
Concerning the specificity of the IM Q-probe method, the method detects not only the 
eight Candida species (C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. 
lusitaniae, C. dubliniensis, C. guilliermondii) but also other kinds of Candida species (C. 
fermentati, C. inconspicua, C. kefyr, C. nivariensis, C. norvegensis, C. orthopsilosis, C. 
pelliculosa, C. sake, C. zeylanoides, etc.) since the Candida universal primer can detect all 
species of Candida. In this regard, the problem is that C. tropicalis and C. orthopsilosis 
cannot be distinguished using the IM Q-probe method (Table S6). Likewise, C. 
guilliermondii, C. fermentati and C. zeylanoides cannot be distinguished as well. However, 
the frequency of other kinds of Candida species causing candidemia is only 0.8 % (Table 
S6), so this does not appear to present an issue in identifying Candida species in clinical 
practice. Of note, regarding specificity, the IM Q-probe method can also identify genus 
Aspergillus and genus Cryptococcus at the genus level (Table S7). It is easy to distinguish 
genus Candida from genus Aspergillus and genus Cryptococcus due to the high specificity 
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of the IM Q-probe identification. However, the purpose of the IM Q-probe method is to 
identify any of eight Candida species in a clinical sample. In order to identify various kinds 
of fungi at the species level, additional developments will be required. 
In conclusion, the IM Q-probe method enabled the rapid identification of eight 
Candida species in a clinical sample within three and a half hours of whole blood collection. 
Furthermore, using the D value, it was possible to quickly identify samples suitable for IM 
Q-probe identification. The IM Q-probe method is expected to contribute not only to the life 
expectancy of candidemia patients but also to antifungal stewardship. 
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Methods 
Candida isolates   
Candida isolated were obtained from patient’s blood, sputum and urine culture isolates at 
Toyama University Hospital, then were sequenced and identified at the species level. 
 
Clinical samples   
A total of 16 whole blood samples were collected from patients with candidemia at Toyama 
University Hospital. All procedures were performed under a protocol approved by the Ethics 
Committee of the University of Toyama, and written informed consent was obtained from 
all patients. The methods were carried out in accordance with the approved guidelines. 
 
Isolation of Candida genomic DNA from colonies 
The Candida colonies were selected with a sterile inoculating loop and suspended in 1 mL 
of molecular-grade distilled water (water deionized and sterilized for molecular biology; 
NACALAI TESQUE, INC., Kyoto, Japan). The sample was subsequently centrifuged at 
20,000×g for 10 minutes, and 900 μL of the supernatant was carefully removed so as not to 
lose the pellet. DNA was isolated from the resulting pellets using a DNA extraction kit 
(QIAamp UCP Pathogen Mini Kit; Qiagen, Hilden, Germany) and glass beads (Pathogen 
Lysis Tubes S; Qiagen) in accordance with the supplier’s instructions. Finally, Candida DNA 
was eluted with 100 μL of elution buffer. 
 
Isolation of Candida genomic DNA from whole blood   
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A total of 2 mL of venous blood was collected in EDTA-2K tube (NIPRO, Osaka, Japan). 
The blood sample was then centrifuged at 100×g for 5 minutes to spin down the blood cells, 
and the resulting supernatant fraction (1 mL) was used. The supernatant was centrifuged 
again at 20,000×g for 10 minutes, and 900 μL of the supernatant fraction was carefully 
removed so as not to disturb the pellet. Next, 1 mL of molecular-grade distilled water (water 
deionized and sterilized for molecular biology; NACALAI TESQUE, INC.) was added to the 
pellet, and the mixture was gently turned upside down several times, and subsequently 
centrifuged again at 20,000×g for 5 minutes. Finally, 1 mL of the supernatant fraction was 
again carefully removed unless you resuspend the pellet. DNA was isolated from the pellet 
using a DNA extraction kit (QIAamp UCP Pathogen Mini Kit; Qiagen) and glass beads 
(Pathogen Lysis Tubes S; Qiagen) in accordance with the supplier’s instructions. Finally, 
Candida DNA was eluted with 100 μL of elution buffer. 
 
PCR assays   
In each of the following processes, the QIAgility system (Qiagen) provided an automated 
PCR setup. The Rotor-Gene Q (Qiagen) was used for the amplification, real-time detection 
of the target DNA and Tm value analysis of the Imperfect Match Quenching probes (IM Q-
probes). All PCR assays were performed as single-tube assays (no multiplex PCR). We used 
1.5 mL PCR-clean Eppendorf tubes that were RNase- and DNase-free (Eppendorf, Hamburg, 
Germany) and 0.2 mL PCR tubes (Qiagen) for PCR. Fungal (Candida) universal primer 
targeting the 18S ribosomal RNA gene (18S rDNA), which has been described previously21, 
were synthesized by Life Technologies Japan, Ltd. (Tokyo, Japan). The IM Q-probes were 
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designed using a multiple alignment software program (Clustal X) and were synthesized by 
NIPPON STEEL and SUMIKIN Eco-Tech Corporation (Ibaragi, Japan). The IM Q-probes 
were as follows: IM Q-probe 1 (5′-CTTTCCTTCTGGGTAGCCATTT-3′, probe size: 22 bp), 
IM Q-probe 2 (5′-TGGAATAATAGAATAGGACGTTATGGTTC-3′, probe size: 29 bp), 
IM Q-probe 3 (5′-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3′, probe size: 32 
bp). 
During the PCR procedure, the PCR reaction mixture (50 μL) contained 7 μL of DNA 
template in KOD FX Neo reagents (1× PCR Buffer with 2.0 mM of Mg2+, 0.4 mM of dNTPs 
and 1 U of KOD FX Neo; TOYOBO LIFE SCIENCE, Osaka, Japan), 0.2 μM of Candida 
universal forward primer, 0.6 μM of Candida universal reverse primer and 0.02 μM of each 
IM Q-probe. 
Each sample was incubated for 5 minutes at 95 °C, then was denatured for 10 seconds 
at 98 °C, annealed for 30 seconds at 57 °C, extended for 20 seconds at 72 °C and subjected 
to fluorescence acquisition for 2 seconds at 82 °C for 50 cycles. 
 
The Tm value analysis   
For the Tm value analysis, the resulting amplicons with each IM Q-probe were heated at 
95 °C for 10 seconds and then cooled at 40 °C for 90 seconds. A post-PCR Tm value analysis 
of the 3 probes was performed from 40 °C to 95 °C, increasing at 1 °C/step. The data profile 
was subsequently analyzed using the Rotor-Gene Q software program, and the Tm values 
were identified. 
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Analytical sensitivity tests   
Prior to performing the sensitivity tests, C. albicans was cultivated in Sabouraud dextrose 
broth at 37 °C for 48 h, and C. albicans suspensions (1 mL) in phosphate-buffered saline 
(PBS) were prepared. A total of 50 µL of the diluted suspensions were inoculated on 
Sabouraud dextrose agar. After incubation at 37 ˚C for 24 h, the number of colony-forming 
units (CFU) was determined by counting the colonies grown on the agar plates in triplicate12. 
The limits of identification and detection were determined by serially diluting cultures 
with known counts (CFU) of C. albicans in PBS and subjecting the samples to IM Q-probe 
identification using the IM Q-probes. The limit of identification was determined to be the 
final dilution of the template in which the IM Q-probe identification result was correct (Table 
S5) with a D value of ≤ 0.41. 
 
A nucleotide sequence-based analysis of fungal genomic DNA   
PCR amplicons amplified the D1-D2 region and the internal transcribed spacer (ITS) regions 
using fungal universal primers were purified (QIAquick PCR Purification Kit; QIAGEN) and 
then sequenced (3500 Genetic Analyzer; Thermo Fisher Scientific, Waltham, 
Massachusetts,  USA)22. An online homology search was performed for strain identification 
using the BLAST nucleotide database tool of the DNA Data Bank of Japan 
(http://www.ddbj.nig.ac.jp/index-j.html). 
 
Culture-based biochemical identification of Candida species 
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The whole blood samples (one aerobic blood culture bottle and one anaerobic blood culture 
bottle) were collected simultaneously with the blood sample for the IM Q-probe analysis 
from the same puncture site. The whole blood samples were then analyzed according to the 
standard methods used by the Clinical Laboratory Center (certified ISO15189) at Toyama 
University Hospital. The blood culture procedures were performed using the BacT/ALERT 
3D system (bioMérieux, Inc., Marcy-l'Étoile, France). Identification of fungi was 
presumptively performed by CHROMagerTM Candida (Becton Dickinson and Company, 
Franklin Lakes, New Jersey, USA) and definitely performed by matrix-assisted laser 
desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Bruker, Billerica, 
Massachusetts, USA). 
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Table 1. Sequence homology between the IM Q-probes and the target regions in the 
eight Candida species 
Candida species 
 IM Q-probe 1 (5′→3′) Mismatch  IM Q-probe 2 (5′→3′) Mismatch  IM Q-probe 3 (5′→3′) Mismatch  CTTTCCTTCTGGGTAGCCATTT  (bp)  TGGAATAATAGAATAGGACGTTATGGTTC (bp)  GCATCAGTAATCAGTTGTCAGAGGAGAAATTC (bp) 
Candida 
albicans  (AF114470) 
 CTTTCCTTCTGGGTAGCCATTT 0  TGGAATAATAGAATAGGACGTTATGGTTC 0  GTATCAGTATTCAGTTGTCAGAGGTGAAATTC 3 
Candida  
glabrata  (AY083231) 
 CTTTCCTTCTGGCTAACCCCAA 6  TGGAATAATGGAATAGGACGTT-TGGTTC 2  GCATCAGTATTCAATTGTCAGAGGTGAAATTC 3 
Candida  
parapsilosis  (AB030915) 
 CTTTCCTTCTGGCTAGCCTTTT 2  TGGAATAATAGAATAGGACGTTATGGTTC 0  GTATCAGTATTCAGTAGTCAGAGGTGAAATTC 4 
Candida  
tropicalis  (KT449837) 
 CTTTCCTTCTGGCTAGCCTTTT 2  TGGAATAATAGAATAGGACGTTATGGTTC 0  GTATCAGTATTCAGTTGTCAGAGGTGAAATTC 3 
Candida  
krusei (AB053239) 
 CTTTCCTTCTGGCTAGCCCTCG 4  TGGAATAATAGAATAGGACGC-ATGGTTC 2  GCATCAGTATTCAGTCGTCAGAGGTGAAATTC 3 
Candida  
lusitaniae  (KU147480) 
 CTTTCCTCCTCCTCTTAGCAAT 12  TGGAATAATAGAATAGGACGC-ATGGTTC 2  GCATCAGTATTCAGTTGTCAGAGGTGAAATTC 2 
Candida  
dubliniensis  (AY497766) 
 CTTTCCTTCTGGCTAGCCATTT 1  TGGAATAATAGAATAGGACGTTATGGTTC 0  GTATCAGTATTCAGTTGTCAGAGGTGAAATTC 3 
Candida  
guilliermondii  (AY497770) 
 CTTTCCTTCTGGCTAACCATTC 3  TGGAATAATAGAATAGGACGTTATGGTTC 0  GCATCAGTATTCAGTTGTCAGAGGTGAAATTC 2 
 
The base sequence differences between the IM Q-probes and the target regions are shown in red.  
 
 
 
 
 
 
 
 
 
 
Table 2. Interpretative criteria 
D Suitability for identification Identification Interpretation 
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0.0 ≤ D ≤ 0.41 High The identification result within this range is the Candida isolate* 
completely matched the Candida 
species registered  
in the database to the base 
sequence level 
0.41 < D 
Medium 
to 
Low 
The identification result with the lowest D is 
highly likely to be the Candida isolate 
Mutant strain, 
polymicrobial infection, or 
not registered in the database 
D, difference value 
* C. lusitaniae and C. glabrata are narrowed down as pathogen, but cannot be distinguished using the D 
value only. In this case, it is easy to distinguish them by checking the difference in their Tm values 
already obtained, which are apparently different (Table S4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. Individual results of identification starting from Candida colonies 
Colonies of Tm degree (°C) D Value IM Q-probe 
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Candida species* IM Q-probe 1  IM Q-probe 2 IM Q-probe 3 Identification results 
C. albicans 62.2 65.5 59.3 0.22 C. albicans 
C. albicans 62.0 65.4 59.1 0.22 C. albicans 
C. albicans 62.3 65.5 59.3 0.29 C. albicans 
C. albicans 62.2 65.5 59.5 0.14 C. albicans 
C. albicans 62.2 65.5 59.5 0.14 C. albicans 
C. albicans 62.3 65.5 59.3 0.29 C. albicans 
C. albicans 62.2 65.5 59.2 0.28 C. albicans 
C. albicans 62.3 65.5 59.5 0.22 C. albicans 
C. albicans 62.4 65.4 59.7 0.37 C. albicans 
C. glabrata - 54.7 57.7 0.14 C. glabrata 
C. glabrata - 55.0 57.8 0 C. glabrata 
C. glabrata - 54.9 57.7 0 C. glabrata 
C. glabrata - 54.9 57.7 0 C. glabrata 
C. glabrata - 55.0 57.8 0 C. glabrata 
C. parapsilosis 53.5 65.2 55.5 0.22 C. parapsilosis 
C. parapsilosis 53.2 65.3 55.3 0.08 C. parapsilosis 
C. parapsilosis 53.4 65.4 55.4 0.08 C. parapsilosis 
C. parapsilosis 53.4 65.4 55.6 0 C. parapsilosis 
C. parapsilosis 53.4 65.4 55.7 0.16 C. parapsilosis 
C. tropicalis 53.4 65.5 59.3 0.16 C. tropicalis 
C. tropicalis 53.4 65.5 59.4 0.22 C. tropicalis 
C. tropicalis 53.5 65.5 59.5 0.22 C. tropicalis 
C. krusei 53.0 59.2 59.0 0.22 C. krusei 
C. krusei 53.0 59.2 59.3 0.36 C. krusei 
C. krusei 53.2 59.0 59.0 0.08 C. krusei 
C. lusitaniae - 59.2 62.3 0 C. lusitaniae 
C. lusitaniae - 59.2 62.2 0 C. lusitaniae 
C. lusitaniae - 59.3 62.3 0.07 C. lusitaniae 
C. dubliniensis 58.0 65.5 59.2 0.08 C. dubliniensis 
C. dubliniensis 58.2 65.5 59.2 0.08 C. dubliniensis 
C. dubliniensis 58.0 65.5 59.5 0.29 C. dubliniensis 
C. guilliermondii 50.2 65.2 62.1 0.08 C. guilliermondii 
C. guilliermondii 50.2 65.4 62.1 0.08 C. guilliermondii 
C. guilliermondii 50.3 65.5 62.3 0.08 C. guilliermondii 
*These Candida species were identified using the sequencing method. 
Table 4. The results of identification starting from whole blood samples artificially 
mixed with Candida species 
Candida species*  Tm degree (°C) D Value IM Q-probe 
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in blood sample IM Q-probe 1 IM Q-probe 2 IM Q-probe 3 Identification results 
C. albicans 61.8 65.3 59.2 0 C. albicans 
C. glabrata - 55.0 58.0 0.14 C. glabrata 
C. parapsilosis 54.0 65.7 56.0 0.22 C. parapsilosis 
C. tropicalis 54.0 65.4 59.7 0.41 C. tropicalis 
C. krusei 53.2 59.3 59.3 0.22 C. krusei 
C. lusitaniae - 59.0 62.3 0.14 C. lusitaniae 
C. dubliniensis 57.8 65.2 59.3 0.33 C. dubliniensis 
C. guilliermondii 50.7 65.5 62.5 0.22 C. guilliermondii 
*These Candida species were identified using the sequencing method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Individual results of identification starting from whole blood samples of 
candidemia patients 
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Patient 
Identification results Match 
Conventional  
culture method Sequencing method IM Q-probe method D Value Cult. Seq. 
HC Not detected Not detected Not detected - - - 
1 C. albicans C. albicans C. albicans 0.22 ✔ ✔ 
2 C. albicans C. albicans C. albicans 0.37 ✔ ✔ 
3 C. albicans C. albicans C. albicans 0.22 ✔ ✔ 
4 C. albicans C. albicans C. albicans 0.22 ✔ ✔ 
5 C. albicans C. albicans C. albicans 0.36 ✔ ✔ 
6 C. albicans C. albicans C. albicans 0.22 ✔ ✔ 
7 C. albicans C. albicans C. albicans 0.14 ✔ ✔ 
8 C. albicans C. albicans C. albicans 0.22 ✔ ✔ 
9 C. albicans C. albicans C. albicans 0.24 ✔ ✔ 
10 C. albicans C. albicans C. albicans 0.14 ✔ ✔ 
11 C. albicans C. albicans C. albicans 0.24 ✔ ✔ 
12 C. parapsilosis C. parapsilosis C. parapsilosis 0.36 ✔ ✔ 
13 C. parapsilosis C. parapsilosis C. parapsilosis 0.37 ✔ ✔ 
14 C. parapsilosis C. parapsilosis C. parapsilosis 0.41 ✔ ✔ 
15 C. parapsilosis C. parapsilosis C. parapsilosis 0.14 ✔ ✔ 
16 C. tropicalis C. tropicalis C. tropicalis 0.22 ✔ ✔ 
 
HC, healthy control; Cult., culture results; Seq., sequencing results 
✔: IM Q-probe identification result matched the culture/sequencing result 
 
 
Figure 1. Workflow of the rapid identification method for eight Candida species within 
three and a half hours of sample collection 
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(A) Using a Candida universal primer and three IM Q-probes, this method rapidly identifies 
eight Candida species by finding the nearest matches of the Tm values in the database. 
(B) We designed three IM Q-probes that can bind the position with some probe-target 
mismatches in the Candida universal PCR amplicon. 
* Candida albicans 18S ribosomal RNA gene (Accession No. AF114470) 
Figure 2. The variations in the three melting peak patterns among the eight Candida 
species 
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red melting peak: IM Q-probe 1, green melting peak: IM Q-probe 2, 
blue melting peak: IM Q-probe 3 
 
 
 
 
 
 
 
 
Figure 3. Difference (D) value 
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In order to identify a Candida isolate, we calculate the difference (D) value using the 
indicated formula. Candida species are identified by comparing the three distances from the 
average of the Candida isolate to those in the database.  
